Cargando…
Structural and Functional Analysis of Laninamivir and its Octanoate Prodrug Reveals Group Specific Mechanisms for Influenza NA Inhibition
The 2009 H1N1 influenza pandemic (pH1N1) led to record sales of neuraminidase (NA) inhibitors, which has contributed significantly to the recent increase in oseltamivir-resistant viruses. Therefore, development and careful evaluation of novel NA inhibitors is of great interest. Recently, a highly po...
Autores principales: | Vavricka, Christopher J., Li, Qing, Wu, Yan, Qi, Jianxun, Wang, Mingyang, Liu, Yue, Gao, Feng, Liu, Jun, Feng, Enguang, He, Jianhua, Wang, Jinfang, Liu, Hong, Jiang, Hualiang, Gao, George F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3197600/ https://www.ncbi.nlm.nih.gov/pubmed/22028647 http://dx.doi.org/10.1371/journal.ppat.1002249 |
Ejemplares similares
-
Long-acting Neuraminidase Inhibitor Laninamivir Octanoate as Post-exposure Prophylaxis for Influenza
por: Kashiwagi, Seizaburo, et al.
Publicado: (2016) -
Immune-mediated Drug-induced Liver Injury Caused by Laninamivir Octanoate Hydrate
por: Kawaguchi, Toshihiro, et al.
Publicado: (2019) -
Laninamivir octanoate for post-exposure prophylaxis of influenza in household contacts: a randomized double blind placebo controlled trial
por: Kashiwagi, Seizaburo, et al.
Publicado: (2013) -
Comparison of the clinical effectiveness of zanamivir and laninamivir octanoate for children with influenza A(H3N2) and B in the 2011–2012 season
por: Koseki, Naoko, et al.
Publicado: (2014) -
Impact of the number of repeated inhalations and patient characteristics on the residual amount of inhaled laninamivir octanoate hydrate dry powder in pediatric patients with influenza
por: Murasaka, Toshiki, et al.
Publicado: (2017)